Trigeminal neuralgia: Difference between revisions
No edit summary |
ClaireLewis (talk | contribs) |
||
| Line 16: | Line 16: | ||
==Management== | ==Management== | ||
===Phenytoin=== | ===[[Phenytoin]]=== | ||
*250mg IV to abort an acute attack | *250mg IV to abort an acute attack | ||
*Relief lasts from four hours to three days | *Relief lasts from four hours to three days | ||
*Fosphenytoin seems to work similarly | *[[Fosphenytoin]] seems to work similarly | ||
===Carbamazepine=== | ===[[Carbamazepine]]=== | ||
*First-line agent with 75% success rate initially | *First-line agent with 75% success rate initially | ||
*Proposed Mechanism: Decreases the response of neurons to peripheral stimulation | *Proposed Mechanism: Decreases the response of neurons to peripheral stimulation | ||
| Line 32: | Line 32: | ||
===Other agents=== | ===Other agents=== | ||
*Baclofen, | *[[Baclofen]], clonazepam, [[valproic acid]], [[lamotrigine]], [[gabapentin]], Oxcarbazepine, [[topiramate]] | ||
===Surgery=== | ===Surgery=== | ||
Revision as of 05:21, 5 October 2016
Background
Clinical Features
- Paroxysms of severe unilateral pain in trigeminal nerve distribution lasting only seconds
- Normal neuro exam
- No pain between paroxysms
- Variant with headache
Differential Diagnosis
Headache
Common
Killers
- Meningitis/encephalitis
- Myocardial ischemia
- Retropharyngeal abscess
- Intracranial Hemorrhage (ICH)
- SAH / sentinel bleed
- Acute obstructive hydrocephalus
- Space occupying lesions
- CVA
- Carbon monoxide poisoning
- Basilar artery dissection
- Preeclampsia
- Cerebral venous thrombosis
- Hypertensive emergency
- Depression
Maimers
- Giant cell arteritis of temporal artery (temporal arteritis)
- Idiopathic intracranial hypertension (Pseudotumor Cerebri)
- Acute Glaucoma
- Acute sinusitis
- Cavernous sinus thrombosis or cerebral sinus thrombosis
- Carotid artery dissection
Others
- Mild traumatic brain injury
- Trigeminal neuralgia
- TMJ pain
- Post-lumbar puncture headache
- Dehydration
- Analgesia abuse
- Various ocular and dental problems
- Herpes zoster ophthalmicus
- Herpes zoster oticus
- Cryptococcosis
- Febrile headache (e.g. pyelonephritis, nonspecific viral infection)
- Ophthalmoplegic migraine
- Superior Vena Cava Syndrome
Aseptic Meningitis
- Viral
- Tuberculosis
- Lyme disease
- Syphilis
- Leptospirosis
- Fungal (AIDS, transplant, chemotherapy, chronic steroid use)
- Noninfectious
Evaluation
- Sensory loss, bilateral involvement, and younger age (<40) are associated with a higher risk of secondary TN, but their absence does not rule out secondary TN
- Consider CT/MRI in these patients to rule out structural etiology
- <5% of patients have V1 distribution, examine carefully for zoster in these patients
Management
Phenytoin
- 250mg IV to abort an acute attack
- Relief lasts from four hours to three days
- Fosphenytoin seems to work similarly
Carbamazepine
- First-line agent with 75% success rate initially
- Proposed Mechanism: Decreases the response of neurons to peripheral stimulation
- Started at 100mg one to two times per day
- Increase by 100-200mg every 3 days
- Usual maintenance dose is 400-800mg (rare >1500mg)
- Pain relief occurs within several hours to days (94% within 48 hours)
- Target serum concentration is 24-43 μmol/L
- If unsuccessful, phenytoin 200-400mg/day is used in combination
Other agents
- Baclofen, clonazepam, valproic acid, lamotrigine, gabapentin, Oxcarbazepine, topiramate
Surgery
- Posterior fossa microvascular decompressive surgery
- Approximately 50% of patients will require surgery
- Successful in 70% of patients
See Also
References
- J Pain Symptom Manage 2001; 21(6):506-510.